131 related articles for article (PubMed ID: 34119435)
41. People living with human immunodeficiency virus and gestational trophoblastic neoplasm.
Barnardt P
Best Pract Res Clin Obstet Gynaecol; 2021 Jul; 74():149-158. PubMed ID: 33176993
[TBL] [Abstract][Full Text] [Related]
42. Gestational Trophoblastic Disease: Clinical and Imaging Features.
Shaaban AM; Rezvani M; Haroun RR; Kennedy AM; Elsayes KM; Olpin JD; Salama ME; Foster BR; Menias CO
Radiographics; 2017; 37(2):681-700. PubMed ID: 28287945
[TBL] [Abstract][Full Text] [Related]
43. PD-L1 Expression in Premalignant and Malignant Trophoblasts From Gestational Trophoblastic Diseases Is Ubiquitous and Independent of Clinical Outcomes.
Bolze PA; Patrier S; Massardier J; Hajri T; Abbas F; Schott AM; Allias F; Devouassoux-Shisheboran M; Freyer G; Golfier F; You B
Int J Gynecol Cancer; 2017 Mar; 27(3):554-561. PubMed ID: 28060141
[TBL] [Abstract][Full Text] [Related]
44. Insights into dovetailing GTD and Cancers.
Nadhan R; Vaman JV; C N; Kumar Sengodan S; Krishnakumar Hemalatha S; Rajan A; Varghese GR; Rl N; Bv AK; Thankappan R; Srinivas P
Crit Rev Oncol Hematol; 2017 Jun; 114():77-90. PubMed ID: 28477749
[TBL] [Abstract][Full Text] [Related]
45. Gestational trophoblastic neoplasia: a meta-analysis evaluating reproductive and obstetrical outcomes after administration of chemotherapy.
Tranoulis A; Georgiou D; Sayasneh A; Tidy J
Int J Gynecol Cancer; 2019 Jul; 29(6):1021-1031. PubMed ID: 31253638
[TBL] [Abstract][Full Text] [Related]
46. Qualitative and quantitative analysis of diffusion-weighted imaging of gestational trophoblastic disease: Can it predict progression of molar pregnancy to persistent form of disease?
Sefidbakht S; Hosseini F; Bijan B; Hamedi B; Azizi T
Eur J Radiol; 2017 Mar; 88():71-76. PubMed ID: 28189211
[TBL] [Abstract][Full Text] [Related]
47. Recognising gestational trophoblastic disease.
Alhamdan D; Bignardi T; Condous G
Best Pract Res Clin Obstet Gynaecol; 2009 Aug; 23(4):565-73. PubMed ID: 19375983
[TBL] [Abstract][Full Text] [Related]
48. Distinct microRNA profiles for complete hydatidiform moles at risk of malignant progression.
Lin LH; Maestá I; St Laurent JD; Hasselblatt KT; Horowitz NS; Goldstein DP; Quade BJ; Sun SY; Braga A; Fisher RA; Berkowitz RS; Elias KM
Am J Obstet Gynecol; 2021 Apr; 224(4):372.e1-372.e30. PubMed ID: 33031755
[TBL] [Abstract][Full Text] [Related]
49. Outcomes of minimally invasive versus open abdominal hysterectomy in patients with gestational trophoblastic disease.
Sugrue R; Foley O; Elias KM; Growdon WB; Sisodia RMC; Berkowitz RS; Horowitz NS
Gynecol Oncol; 2021 Feb; 160(2):445-449. PubMed ID: 33272644
[TBL] [Abstract][Full Text] [Related]
50. Gestational trophoblastic disease in Sanliurfa, southeast Anatolia, Turkey.
Harma M; Harma M; Yurtseven S; Gungen N
Eur J Gynaecol Oncol; 2005; 26(3):306-8. PubMed ID: 15991533
[TBL] [Abstract][Full Text] [Related]
51. Clinical presentation and diagnosis of Gestational Trophoblastic Disease.
Lok C; Frijstein M; van Trommel N
Best Pract Res Clin Obstet Gynaecol; 2021 Jul; 74():42-52. PubMed ID: 33422446
[TBL] [Abstract][Full Text] [Related]
52. Imaging in Gestational Trophoblastic Disease.
Lin LH; Polizio R; Fushida K; Francisco RPV
Semin Ultrasound CT MR; 2019 Aug; 40(4):332-349. PubMed ID: 31375173
[TBL] [Abstract][Full Text] [Related]
53. Gestational trophoblastic neoplasia management: an update.
Ngan S; Seckl MJ
Curr Opin Oncol; 2007 Sep; 19(5):486-91. PubMed ID: 17762576
[TBL] [Abstract][Full Text] [Related]
54. Experience with platinum-based and high-dose chemotherapy in patients with gestational trophoblastic disease: possible implications for future management.
Markman M
J Cancer Res Clin Oncol; 2004 Jul; 130(7):383-7. PubMed ID: 15150657
[TBL] [Abstract][Full Text] [Related]
55. Update on the diagnosis and management of gestational trophoblastic disease.
Ngan HYS; Seckl MJ; Berkowitz RS; Xiang Y; Golfier F; Sekharan PK; Lurain JR; Massuger L
Int J Gynaecol Obstet; 2018 Oct; 143 Suppl 2():79-85. PubMed ID: 30306586
[TBL] [Abstract][Full Text] [Related]
56. Centralized Coordination of Decentralized Assistance for Patients with Gestational Trophoblastic Disease in Brazil: A Viable Strategy for Developing Countries.
Braga A; Burlá M; Freitas F; Uberti E; Viggiano M; Sun SY; Maestá I; Elias KM; Berkowitz RS;
J Reprod Med; 2016; 61(5-6):224-9. PubMed ID: 27424363
[TBL] [Abstract][Full Text] [Related]
57. A 10-Year Clinical Experience of Gestational Trophoblastic Disease at Rajavithi Hospital, 2001-2010.
Yanaranop M; Potikul C; Tuipae S
J Med Assoc Thai; 2016 Feb; 99 Suppl 2():S17-27. PubMed ID: 27266212
[TBL] [Abstract][Full Text] [Related]
58. Gestational trophoblastic disease.
Seckl MJ; Sebire NJ; Berkowitz RS
Lancet; 2010 Aug; 376(9742):717-29. PubMed ID: 20673583
[TBL] [Abstract][Full Text] [Related]
59. Robotic-assisted Laparoscopic Management of Chemoresistant Myoinvasive Complete Molar Pregnancy.
Riley K; Newell J; Zaino R; Kesterson J
J Minim Invasive Gynecol; 2015; 22(6):1100-3. PubMed ID: 26009277
[TBL] [Abstract][Full Text] [Related]
60. Comparing and evaluating the efficacy of methotrexate and actinomycin D as first-line single chemotherapy agents in low risk gestational trophoblastic disease.
Lee YJ; Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
J Gynecol Oncol; 2017 Mar; 28(2):e8. PubMed ID: 27819410
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
